Lung Cancer Minimal Residual Disease Detection Using an Integrated cfDNA and cfRNA Approach
Reference number | |
Coordinator | Oncodia AB |
Funding from Vinnova | SEK 4 992 000 |
Project duration | June 2025 - June 2028 |
Status | Ongoing |
Venture | Eurostars |
Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Lung Cancer Minimal Residual Disease Detection Using an Integrated cfDNA and cfRNA Approach
Reference number | 2025-00040 |
Coordinator | Oncodia AB |
Funding from Vinnova | SEK 4 992 000 |
Project duration | June 2025 - June 2028 |
Status | Ongoing |
Venture | Eurostars |
Last updated 25 March 2025
Reference number 2025-00040